Max Robotics — Global Service Robot Directory + US Certification

About

Isacco Desideri is a leading figure in the field of stereotactic radiotherapy, with a particular focus on treating recurrent and metastatic cancers using robotic radiosurgery systems. His research centers on the application of CyberKnife technology to deliver high-dose, precisely targeted radiation to challenging anatomical sites. Desideri’s major contributions include pioneering work on stereotactic body radiotherapy (SBRT) for cardiac malignancies, demonstrating that radiobiological and technical barriers to treating heart tumors can be overcome with modern robotic systems. His most cited paper (50 citations) explores robotic stereotactic retreatment for biochemical control in previously irradiated patients with recurrent prostate cancer, offering a salvage option for this difficult clinical scenario. He has also advanced the treatment of liver oligometastases from colorectal cancer, reporting promising outcomes from a single-center experience. Beyond clinical applications, Desideri contributed to quality assurance in radiotherapy through the development of the ADAM phantom, a tool for testing 4D medical imaging and dose delivery devices in moving targets. His work bridges technical innovation and clinical practice, providing new treatment pathways for patients with limited options.